End Price Gouging for Medications Act

# End Price Gouging for Medications Act - Summary **What the Bill Would Do** The End Price Gouging for Medications Act would establish new federal restrictions on how much pharmaceutical companies can raise prices on existing medications. Rather than allowing companies to set prices freely, the bill would limit price increases to protect consumers from what sponsors view as excessive "price gouging." The exact price increase limits and enforcement mechanisms aren't detailed in the information provided, but the bill aims to make medications more affordable for patients and reduce out-of-pocket drug costs. **Who It Affects** This bill would primarily impact pharmaceutical companies, which would face new constraints on their pricing decisions, and patients who take medications, who could see lower drug costs. It could also affect health insurance companies, pharmacies, and government health programs like Medicare that pay for drugs.

Any American who purchases prescription medications would potentially benefit from lower prices if the bill passes. **Current Status** As of now, the bill (HR 3391) remains in committee and has not advanced to a full House vote. It was introduced by Representative Debbie Dingell, a Democrat from Michigan. The bill is still in the early legislative stage and would need committee approval and broader congressional support to move forward.